Lansing Street Advisors’s Pfizer PFE Stock Holding History

Lansing Street Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,063	Closed	-$291K	–	132
2024 Q3	$291K	Sell	10,063 -2,387	-19%	-$69.6K	0.11%	92
2024 Q2	$348K	Buy	12,450 +454	+4%	+$12.5K	0.15%	78
2024 Q1	$333K	Buy	+11,996	New	+$333K	0.15%	72
2023 Q2	$419K	Sell	11,432 -1,676	-13%	-$65.2K	0.24%	58
2023 Q1	$535K	Sell	13,108 -6,744	-34%	-$291K	0.33%	55
2022 Q4	$1.02M	Buy	19,852 +1,420	+8%	+$68.1K	0.7%	34
2022 Q3	$807K	Buy	18,432 +159	+0.9%	+$7.73K	0.62%	35
2022 Q2	$958K	Buy	18,273 +134	+0.7%	+$6.83K	0.75%	32
2022 Q1	$1M	Buy	+18,139	New	+$941K	0.64%	36

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lansing Street Advisors's PFE Position: Q4 2024 in Review

Lansing Street Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,063 shares — an estimated $291K sold.

Lansing Street Advisors first reported a position in PFE in Q1 2022 and held it in 9 quarters. The position peaked at $1.02M in Q4 2022. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Lansing Street Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Lansing Street Advisors sold 10,063 Pfizer shares in Q4 2024, an estimated $291K.
Lansing Street Advisors first reported a position in Pfizer in Q1 2022 and held it in 9 quarters.
Lansing Street Advisors's Pfizer position peaked at $1.02M in Q4 2022.
2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Lansing Street Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.